CC
ARNA

Callan Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Callan Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,200
Closed -$21K – 65
2016
Q2 		$21K Buy
+1,200
New +$21.5K 0.01% 68
2015
Q3 		– Sell
-23,200
Closed -$1.08M – 74
2015
Q2 		$1.08M Sell
23,200
-3,000
-11% -$130K 0.23% 42
2015
Q1 		$1.15M Buy
26,200
+8,095
+45% +$376K 0.24% 40
2014
Q4 		$628K Buy
18,105
+10,493
+138% +$426K 0.14% 50
2014
Q3 		$319K Buy
7,612
+1,000
+15% +$44.6K 0.09% 57
2014
Q2 		$387K Buy
+6,612
New +$416K 0.1% 53

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Callan Capital's ARNA Position: Q3 2016 in Review

Callan Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2016, closing a stake of 1,200 shares — an estimated $21K sold.

Callan Capital first reported a position in ARNA in Q2 2014 and held it in 6 quarters. The position peaked at $1.15M in Q1 2015. 125 funds tracked by Wall St. Rank hold ARNA as of Q3 2016.

  • Callan Capital reported no remaining Arena Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Callan Capital sold 1,200 Arena Pharmaceuticals Inc shares in Q3 2016, an estimated $21K.
  • Callan Capital first reported a position in Arena Pharmaceuticals Inc in Q2 2014 and held it in 6 quarters.
  • Callan Capital's Arena Pharmaceuticals Inc position peaked at $1.15M in Q1 2015.
  • 125 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2016.

Based on Callan Capital's 13F filing for Q3 2016, filed 15 Nov 2016.